Belkyra Treatment

BELKYRA™
may be right for you if:


  • You’re bothered by fat under the chin, also known as submental fullness/fat.
  • You feel this makes you look older or heavier than you actually are.
  • You want a procedure with no downtime
  • You eat well and exercise, but the “double chin” does not go away.

(Known as Kybella™in the US)

Price: $1200/20 injections + gst
Additional: $60/injection + gst

How does it work?

The active ingredient in BELKYRA™ is synthetic deoxycholic acid. Deoxycholic acid is a naturally occurring molecule in the body that aids in the breakdown and absorptio​n of dietary fat.

When injected into the fat beneath the chin, BELKYRA™ destroys fat cells, resulting in a noticeable reduction in fullness under the chin. Once destroyed, these cells can no longer store or accumulate fat, so further treatment is not expected once you reach your desired esthetic goal.

What to expect?

Before starting treatment, your healthcare provider will examine the area under and around your chin to determine if BELKYRA™ is right for you. Then, your physician will tailor your treatment to the amount of fat under the chin and your esthetic goals.

Treatment can only be administered by a BELKYRA™-trained healthcare provider. At each treatment, you will receive multiple small injections under your chin, and the injection process takes about 15 to 20 minutes.

The exact number of injections will depend on the amount of fat you have under your chin and your desired profile. A skin marking grid is placed under your chin, and this will indicate the number of injections that you receive on that day.

Who can get it?

BELKYRA™ can be used for anyone, male or female, who is bothered by the fat under their chin. Being overweight is not the only cause of a “double chin”.

It is caused by weight gain, aging and genetics.

Who cannot get it?

(1) BELKYRA™ is contraindicated in the presence of infection at the injection sites.

(2) Patients with prominent platysmal bands or excessive skin laxity may not achieve esthetically desirable results.

(3) BELKYRA™ should be avoided in patients who have a current or prior history of dysphagia or a cause of submental fullness other than submental fat (e.g., thyroid abnormality or cervical lymphadenopathy)

(4) It must be used with caution in patients who have had prior surgical or esthetic treatment of the submental area.

(5) It must be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy.

Side Effects

Common side effects:

The most commonly reported adverse reactions in the pivotal clinical trials were:

  • injection-site edema/swelling,
  • hematoma/bruising,
  • pain,
  • numbness,
  • erythema,
  • induration
Serious (uncommon) side effects:

Nerve injury in the jaw that can temporarily cause an uneven smile or facial muscle weakness (experienced by 4 out of 100 people in clinical studies) and trouble swallowing (experienced by 2 out of 100 people in clinical studies).

In clinical studies, nerve injury in the jaw resolved on its own in a median of 44 days (range of 1 to 298 days), and trouble swallowing resolved on its own in a median of 3 days (range of 1 to 81 days).